Cost Benefit Analysis

Cardiac Assessment Prior to Vascular Surgery: Is Dipyridamole-Sestamibi Necessary?

Vascular Surgery / Electrocardiography / Humans / Female / Male / Cost effectiveness / Acute Myocardial Infarction / Risk factors / Clinical Sciences / Aged / Middle Aged / Myocardial Infarction / Coronary heart disease / Diabetes complications / Cost Benefit Analysis / Retrospective Studies / Angina pectoris / Sudden Cardiac Death / Age Factors / Risk Factors / Perioperative myocardial infarction / Radiopharmaceuticals / Sensitivity and Specificity / Coronary artery bypass surgery / Unstable Angina / Cost effectiveness / Acute Myocardial Infarction / Risk factors / Clinical Sciences / Aged / Middle Aged / Myocardial Infarction / Coronary heart disease / Diabetes complications / Cost Benefit Analysis / Retrospective Studies / Angina pectoris / Sudden Cardiac Death / Age Factors / Risk Factors / Perioperative myocardial infarction / Radiopharmaceuticals / Sensitivity and Specificity / Coronary artery bypass surgery / Unstable Angina

Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis

Biological Sciences / Humans / Animals / Chagas disease / Trypanosoma Cruzi / Cost Benefit Analysis / World Health Organization / Recombinant Proteins / Enzyme Linked Immunosorbent Assay / Cost Benefit Analysis / World Health Organization / Recombinant Proteins / Enzyme Linked Immunosorbent Assay

Análise de Custo-Efetividade da Sinvastatina versus Atorvastatina na Prevenção Secundária de Eventos Cardiovasculares no Sistema Único de Saúde Brasileiro

Brazil / Treatment Outcome / Risk assessment / Cardiovascular disease / Applied Economics / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin

Análise de custo-efetividade de métodos preventivos para superfície oclusal de acordo com o risco de cárie: resultados de um ensaio clínico controlado

Humans / Child / Female / Dental Caries / Male / Cost Benefit Analysis / Acrylic Resins / Silicon Dioxide / Cost Benefit Analysis / Acrylic Resins / Silicon Dioxide

Procedures for establishing defensible programmes for assessing practice performance

Education / Medical Education / Quality of Mental Health Care / Humans / Cost Benefit Analysis / Reproducibility of Results / Clinical Competence / Medical / Reproducibility of Results / Clinical Competence / Medical

Single versus double embryo transfer: cost-effectiveness analysis alongside a randomized clinical trial

Human / Twins / Pregnancy / Humans / Cost Effectiveness Analysis / Female / Netherlands / Cost effectiveness / Embryo Transfer / Human reproduction / Adult / Willingness to Pay / Cost Benefit Analysis / Randomized Clinical Trial / Fertilization in Vitro / Point of View / Health Care Costs / Embryos / Pregnancy Rate / Twin Pregnancy / Female / Netherlands / Cost effectiveness / Embryo Transfer / Human reproduction / Adult / Willingness to Pay / Cost Benefit Analysis / Randomized Clinical Trial / Fertilization in Vitro / Point of View / Health Care Costs / Embryos / Pregnancy Rate / Twin Pregnancy

Randomized Trial of a Specialist Genetic Assessment Service for Familial Breast Cancer

Genetics / Breast Cancer / Risk / Anxiety / Prospective studies / Humans / Genetic Testing / Wales / Female / Patient Satisfaction / Randomized Trial / Middle Aged / Adult / Patient Care Team / Cost Benefit Analysis / ANXIETY / Humans / Genetic Testing / Wales / Female / Patient Satisfaction / Randomized Trial / Middle Aged / Adult / Patient Care Team / Cost Benefit Analysis / ANXIETY

Single versus double embryo transfer: cost-effectiveness analysis alongside a randomized clinical trial

Human / Twins / Pregnancy / Humans / Cost Effectiveness Analysis / Female / Netherlands / Cost effectiveness / Embryo Transfer / Human reproduction / Adult / Willingness to Pay / Cost Benefit Analysis / Randomized Clinical Trial / Fertilization in Vitro / Point of View / Health Care Costs / Embryos / Pregnancy Rate / Twin Pregnancy / Female / Netherlands / Cost effectiveness / Embryo Transfer / Human reproduction / Adult / Willingness to Pay / Cost Benefit Analysis / Randomized Clinical Trial / Fertilization in Vitro / Point of View / Health Care Costs / Embryos / Pregnancy Rate / Twin Pregnancy

Randomized Trial of a Specialist Genetic Assessment Service for Familial Breast Cancer

Genetics / Breast Cancer / Risk / Anxiety / Prospective studies / Humans / Genetic Testing / Wales / Female / Patient Satisfaction / Randomized Trial / Middle Aged / Adult / Patient Care Team / Cost Benefit Analysis / ANXIETY / Humans / Genetic Testing / Wales / Female / Patient Satisfaction / Randomized Trial / Middle Aged / Adult / Patient Care Team / Cost Benefit Analysis / ANXIETY

Single versus double embryo transfer: cost-effectiveness analysis alongside a randomized clinical trial

Human / Twins / Pregnancy / Humans / Cost Effectiveness Analysis / Female / Netherlands / Cost effectiveness / Embryo Transfer / Human reproduction / Adult / Willingness to Pay / Cost Benefit Analysis / Randomized Clinical Trial / Fertilization in Vitro / Point of View / Health Care Costs / Embryos / Pregnancy Rate / Twin Pregnancy / Female / Netherlands / Cost effectiveness / Embryo Transfer / Human reproduction / Adult / Willingness to Pay / Cost Benefit Analysis / Randomized Clinical Trial / Fertilization in Vitro / Point of View / Health Care Costs / Embryos / Pregnancy Rate / Twin Pregnancy

Estudo exploratório de custos e conseqüências do pré-natal no Programa Saúde da Família

Program Evaluation / Primary Health Care / Evaluation / Developing Countries / Brazil / Health / Pregnancy / Humans / Female / Newborn Infant / Family Health / Public health systems and services research / Cost Benefit Analysis / Perinatal mortality / Prenatal Care / Health / Pregnancy / Humans / Female / Newborn Infant / Family Health / Public health systems and services research / Cost Benefit Analysis / Perinatal mortality / Prenatal Care

Presenting Germany’s drug pricing rule as a cost-per-QALY rule

Quality of Mental Health Care / Germany / Humans / Prescription drugs / Quality adjusted life years / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Drug Industry / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Drug Industry

Stoma coloproctology nurse specialist: a case study

Psychology / Nursing / Social Support / Humans / Skin Care / Northern Ireland / Case Study / Clinical / Colorectal Surgery / Questionnaires / Professional Autonomy / Cost Benefit Analysis / Organizational Innovation / Clinical Competence / Nursing Assessment / Clinical Nursing / Northern Ireland / Case Study / Clinical / Colorectal Surgery / Questionnaires / Professional Autonomy / Cost Benefit Analysis / Organizational Innovation / Clinical Competence / Nursing Assessment / Clinical Nursing

Stoma coloproctology nurse specialist: a case study

Psychology / Nursing / Social Support / Humans / Skin Care / Northern Ireland / Case Study / Clinical / Colorectal Surgery / Questionnaires / Professional Autonomy / Cost Benefit Analysis / Organizational Innovation / Clinical Competence / Nursing Assessment / Clinical Nursing / Northern Ireland / Case Study / Clinical / Colorectal Surgery / Questionnaires / Professional Autonomy / Cost Benefit Analysis / Organizational Innovation / Clinical Competence / Nursing Assessment / Clinical Nursing

Antivirais incorporados no Brasil para hepatite B cronica: analise de custo-efetividade

Brazil / Treatment Outcome / Humans / Markov chains / Adult / Public health systems and services research / Analysis of Variance / Cost Benefit Analysis / Disease Progression / Hepatitis B virus / Lamivudine / Adenine / Antiviral Agents / Public health systems and services research / Analysis of Variance / Cost Benefit Analysis / Disease Progression / Hepatitis B virus / Lamivudine / Adenine / Antiviral Agents
Copyright © 2017 DADOSPDF Inc.